Literature DB >> 6274413

Tripeptidyl carboxypeptidase activity of kininase II (angiotensin-converting enzyme).

J Inokuchi, A Nagamatsu.   

Abstract

The degradation of des-Arg9-brady kinin and its analogues by highly purified preparations of hog lung and kidney kininase II (angiotensin-converting enzyme; peptidyldipeptide hydrolase, EC 3.4.15.1) was studied. The degradative peptides fragments were separated and isolated by high performance liquid chromatography and identified by amino acid analysis. Both enzymes released C-terminal tripeptides from des-Arg9-bradykinin, des-Arg9-(Leu8)-bradykinin, Pro-Pro-Gly-Phe-Ser-Pro-Phe, Pro-Gly-Phe-Ser-Pro-Phe, Gly-Phe-Ser-Pro-Phe, Bz-Gly-Ser-pro-Phe and Bz-Gly-Ala-Pro-Phe. Hydrolysis of Phe-Ser-Pro-Phe, Bz-Gly-His-Pro-Phe, Bz-Gly-Phe-Pro-Phe and Bz-Gly-Gly-Pro-Phe by both enzymes was negligible. These data indicate that kininase II can release C-terminal tripeptides of substrates having a proline residue in the penultimate position such as des-Arg9-bradykinin and its analogues, and that this enzyme is able not only to act as a dipeptidyl carboxypeptidase but also acts as a tripeptidyl carboxy-peptidase. The tripeptidyl carboxypeptidase enzyme was sensitive to inhibition by kininase II inhibitors.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6274413     DOI: 10.1016/0005-2744(81)90042-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  Functional evidence of des-Arg10-kallidin enzymatic inactivating pathway in isolated human umbilical vein.

Authors:  Wanda Nowak; Ezequiel Dario Goldschmidt; Alejandra Georgina Falcioni; Mariana Ines Pugliese; Andrea Emilse Errasti; Facundo German Pelorosso; Federico Manuel Daray; Juan Ezequiel Gago; Rodolfo Pedro Rothlin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-03-20       Impact factor: 3.000

2.  Novel activity of human angiotensin I converting enzyme: release of the NH2- and COOH-terminal tripeptides from the luteinizing hormone-releasing hormone.

Authors:  R A Skidgel; E G Erdös
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

3.  Cleavage of des-Arg9-bradykinin by angiotensin I-converting enzyme from pig kidney cortex.

Authors:  G Oshima; Y Hiraga; K Shirono; S Oh-ishi; S Sakakibara; T Kinoshita
Journal:  Experientia       Date:  1985-03-15

4.  Degradation pathway of kinins in tumor ascites and inhibition by kininase inhibitors: analysis by HPLC.

Authors:  Y Matsumura; H Maeda; H Kato
Journal:  Agents Actions       Date:  1990-03

5.  Human recombinant membrane-bound aminopeptidase P: production of a soluble form and characterization using novel, internally quenched fluorescent substrates.

Authors:  Giuseppe Molinaro; Adriana K Carmona; Maria A Juliano; Luiz Juliano; Elena Malitskaya; Marie-Andrée Yessine; Miguel Chagnon; Yves Lepage; William H Simmons; Guy Boileau; Albert Adam
Journal:  Biochem J       Date:  2005-01-15       Impact factor: 3.857

6.  Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy of enzymes associated with bradykinin-mediated angioedema.

Authors:  R M Fryer; J Segreti; P N Banfor; D L Widomski; B J Backes; C W Lin; S J Ballaron; B F Cox; J M Trevillyan; G A Reinhart; T W von Geldern
Journal:  Br J Pharmacol       Date:  2007-12-17       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.